Overall survival from the phase 3 POLO trial: Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer Meeting Abstract
| Authors: | Golan, T.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; Oh, D. Y.; Reinacher-Schick, A. C.; Tortora, G.; Algül, H.; O'Reilly, E. M.; McGuinness, D.; Cui, K. R.; Schlienger, K.; Locker, G. Y.; Kindler, H. L. |
| Abstract Title: | Overall survival from the phase 3 POLO trial: Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer |
| Meeting Title: | 2021 Gastrointestinal Cancers Symposium (ASCO GI) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 15-17 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-01-20 |
| Language: | English |
| ACCESSION: | WOS:000636712800383 |
| DOI: | 10.1200/JCO.2021.39.3_suppl.378 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 378 -- Source: Wos |
